PMEL and melanoma: It was postulated also the evaluation of melanoma markers on circulating cells asMelan A, gp100, MAGE3, MIA (melanoma inhibitory antigen) prior to the treatment andwithin the therapy were compared to the data collected at baseline after the melanomasurgery.